Home › Research › Getting a diagnosis
Editorial: On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use
Robin Ziyue Zhou, Anders Wimo, Bengt Winblad. The Journal of Prevention of Alzheimer's Disease, 2024-07-08
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This editorial pushes back against the 2024 revised Alzheimer's diagnostic criteria, arguing it is premature to label people as having Alzheimer's disease based on biomarkers alone when they have no symptoms and may never develop dementia. The authors warn this could cause unnecessary anxiety, over-labeling, and commercial exploitation without any proven benefit for asymptomatic people.
What this study adds
Evidence grade: Not rated
Anti-amyloid drugs that clear amyloid plaques do not consistently stop cognitive decline, suggesting that amyloid alone is not a reliable target for treating or preventing Alzheimer's disease. Its stated limit: This is an editorial/commentary, not original research; it has no participants, effect size, or study design of its own.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zhou, R. Z., Wimo, A., & Winblad, B. (2024). Editorial: On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use. The Journal of Prevention of Alzheimer's Disease.
Vancouver
Zhou RZ, Wimo A, Winblad B. Editorial: On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use. The Journal of Prevention of Alzheimer's Disease. 2024.
BibTeX
@article{zhou2024-33dd7a84,
author = {Zhou, Robin Ziyue and Wimo, Anders and Winblad, Bengt},
title = {{Editorial: On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use}},
journal = {The Journal of Prevention of Alzheimer's Disease},
year = {2024}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Many people with amyloid buildup never develop dementia, so biomarker-only diagnosis risks over-labeling
- Anti-amyloid drug trials show amyloid clearance does not always stop cognitive decline, questioning amyloid-only definitions
- The criteria could classify over 20% of adults 50+ as having 'Alzheimer's disease' with no proven preventive treatment available for them
- Authors recommend calling amyloid-positive, symptom-free people 'at risk for AD' rather than diagnosing AD
Why it matters
Anti-amyloid drugs that clear amyloid plaques do not consistently stop cognitive decline, suggesting that amyloid alone is not a reliable target for treating or preventing Alzheimer's disease. Diagnosing Alzheimer's disease in asymptomatic people based solely on biomarkers lacks evidence of benefit and risks causing unnecessary anxiety for people who may never develop dementia.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Limitations
This is an editorial/commentary, not original research; it has no participants, effect size, or study design of its own.
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people, randomized / blinded and indexed in PubMed because the record does not state it. We have no data on strength of evidence, journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 21 of the 57 points we could judge it on, which is 37 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The Journal of Prevention of Alzheimer's Disease) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 0 / 2 | No PubMed ID and no DOI — scores zero (not stated in the record — scored 0) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 21 / 57 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 21 of the 57 points we could judge it on is 37 out of 100. |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Getting a diagnosis from nearby years
Also in Getting a diagnosis
141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.